TI
AVNS icon

Trexquant Investment’s Avanos Medical AVNS Stock Holding History

Trexquant Investment’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.89M Buy
277,535
+248,349
+851% +$3.35M 0.03% 756
2025
Q4 		$328K Sell
29,186
-105,242
-78% -$1.2M ﹤0.01% 1435
2025
Q3 		$1.55M Buy
134,428
+120,348
+855% +$1.41M 0.02% 1000
2025
Q2 		$172K Sell
14,080
-178,870
-93% -$2.25M ﹤0.01% 1458
2025
Q1 		$2.76M Buy
+192,950
New +$3.01M 0.03% 747
2024
Q4 		– Sell
-13,208
Closed -$317K – 1545
2024
Q3 		$317K Buy
13,208
+1,150
+10% +$26.3K ﹤0.01% 1339
2024
Q2 		$240K Sell
12,058
-8,265
-41% -$161K ﹤0.01% 1411
2024
Q1 		$405K Sell
20,323
-27,023
-57% -$522K 0.01% 1211
2023
Q4 		$1.06M Buy
47,346
+9,803
+26% +$202K 0.02% 805
2023
Q3 		$759K Buy
+37,543
New +$851K 0.02% 857
2023
Q1 		– Sell
-25,619
Closed -$693K – 1432
2022
Q4 		$693K Buy
25,619
+11,186
+78% +$274K 0.02% 784
2022
Q3 		$314K Sell
14,433
-2,871
-17% -$75K 0.01% 1010
2022
Q2 		$473K Sell
17,304
-33,915
-66% -$974K 0.02% 853
2022
Q1 		$1.72M Buy
51,219
+21,368
+72% +$688K 0.08% 302
2021
Q4 		$1.03M Buy
29,851
+22,498
+306% +$727K 0.06% 375
2021
Q3 		$229K Buy
+7,353
New +$249K 0.02% 888
2021
Q2 		– Sell
-5,763
Closed -$252K – 1092
2021
Q1 		$252K Buy
+5,763
New +$270K 0.02% 839
2018
Q4 		– Sell
-18,670
Closed -$1.28M – 1026
2018
Q3 		$1.28M Sell
18,670
-9,413
-34% -$606K 0.1% 291
2018
Q2 		$1.61M Buy
+28,083
New +$1.48M 0.11% 268
2016
Q3 		– Sell
-16,728
Closed -$544K – 727
2016
Q2 		$544K Buy
16,728
+2,828
+20% +$86.6K 0.07% 449
2016
Q1 		$399K Buy
+13,900
New +$370K 0.05% 643
2015
Q4 		– Sell
-25,600
Closed -$728K – 1002
2015
Q3 		$728K Buy
25,600
+12,300
+92% +$429K 0.06% 565
2015
Q2 		$538K Buy
+13,300
New +$597K 0.06% 583

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Trexquant Investment's AVNS Position: Q1 2026 in Review

Trexquant Investment increased its Avanos Medical (AVNS) stake by 851% in Q1 2026, buying an estimated $3.35M and bringing the position to 277,535 shares worth $3.89M. The position accounts for 0.03% of the portfolio, ranked #756.

Trexquant Investment first reported a position in AVNS in Q2 2015 and has held it in 23 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Trexquant Investment held 277,535 shares of Avanos Medical worth $3.89M as of Q1 2026.
  • Trexquant Investment bought 248,349 Avanos Medical shares in Q1 2026, an estimated $3.35M.
  • Avanos Medical made up 0.03% of Trexquant Investment's portfolio in Q1 2026, its #756 holding.
  • Trexquant Investment first reported a position in Avanos Medical in Q2 2015 and has held it in 23 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.